*Note: This short is expensive and will open up negative if you have to get filled higher than the market.
This is a 1 of 2 short position open.
This stock recently beat a Phase II study. Causing it to gap up AH. Currently up 70% in the last 24 hours. There is a Phase 3 coming up which can cause another 30% to 50%+ run. So, yes this is a high-risk trade.
I expect this company to hit $170 by the end of the day.